AMETEK Acquires Paragon Medical for $1.9 Billion
AMETEK, Inc. announced that it has entered into a definitive agreement to acquire Paragon Medical from affiliates of American Securities LLC. The all-cash transaction is valued at approximately $1.9 billion. Paragon Medical, formerly MW Life Sciences, offers advanced medical manufacturing and design for medical devices, components and products. It is based in Pierceton, Indiana. Paragon Medical serves a wide range of specialty applications including orthopedics, minimally invasive surgery, robotic surgery and drug delivery. Paragon’s product portfolio includes single-use and consumable surgical instruments and implantable components sold to a diverse blue-chip customer base of... Read More »
Danaher Disappoints with Q3:23 Sales and Profit Decline
Danaher Corp. (NYSE: DHR), a well-known player in the medical device market, recently unveiled its third-quarter financial results on October 24. With a global presence, Danaher specializes in the design, manufacture and distribution of professional, medical, industrial and commercial products and services. The latest earnings report painted a somber picture for Danaher, as the company grappled with a decline in both sales and profits compared to the previous year. This underwhelming performance came as the pharma and biotech sectors experienced a broader loss of momentum in critical markets. “Pharma and biotech took a modest step down, and that was particularly the case in the U.S. In... Read More »
TriSpan Acquires SmartArches
TriSpan announced its acquisition of SmartArches from ProSmile, a multi-specialty dental organization in New Jersey, Pennsylvania and Maryland. Founded in December 2022, SmartArches is a specialty implant-focused dental company with a network of oral surgeons, implant and restorative dentists. It serves patients in eight locations throughout the United States. With offices in New York and London, TriSpan is a private equity firm that invests in lower middle market companies in North America, Europe and the United Kingdom with annual revenues ranging from $20-100 million. It was founded in 2015. According to data captured in the LevinPro HC database, this transaction... Read More »
Haemonetics Corporation Buys Medical Device Company OpSens
Haemonetics Corporation has announced that it has entered into a definitive agreement to acquire all outstanding shares of OpSens. According to data captured in the LevinPro HC database, this transaction represents the 86th Medical Devices transaction of 2023. OpSens is being acquired for $2.90 CAD per share in an all-cash transaction representing a fully diluted equity value of approximately $253 million USD at the current exchange rate. OpSens is a Canadian medical device cardiology-focused company. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesion access. The... Read More »
AirLife Acquires Avanos Medical’s Respiratory Assets
AirLife, based in Grand Rapids, Michigan, announced its acquisition of Avanos Medical, Inc.’s Respiratory health business on October 2. Goodwin Procter LLP is acting as legal counsel to AirLife. Terms were not disclosed. Avanos Medical’s respiratory health business includes BALLARD, MICROCUFF and the endOclear® product lines. AirLife is also purchasing two of Avano’s manufacturing facilities. Avanos Medical is a medical technology company focused on delivering clinically superior medical device solutions. Its services include providing a vital lifeline for nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
